Connecting the DOTS: Spectre of a public health iatrogenesis

Indian Journal of Community Medicine

Volumn 37, Issue 1, 2012, Pages 13-15

  Dasgupta, Rajib ^a   Ghanashyam, I ^b  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b Municipal Corporation of Delhi   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859021982     PISSN: 09700218     EISSN: 19983581     Source Type: Journal    
DOI: 10.4103/0970-0218.94011     Document Type: Note

References (16)

1. Available from: http://articles.timesofindia.indiatimes. com/2012-01-07/india/30601741-1-multi-drug-resistant-tb-tbpatients-tb-germs [Last accessed on 2012 Jan 12].
2. Available from: http://www.tbcindia.nic.in, 2nd Quarter PERF. 2011, DOTS PLUS implementation, diagnosis and interim report. [Last accessed on 2012 Jan 12].
3. Registrar General of India. Report on Causes of Deaths in India 2001-2003; p 54. New Delhi: Government of India; 2010.
4. Sadacharam K, Gopi PG, Chandrasekaran V, Eusuff SI, Subramani R, Santha T, et al. Status of semar-positive TB patients at 2-3 years after initiation of treatment under a DOTS programme. Indian J Tuberc 2007;54:199-203.
5. Chandrasekaran V, Gopi PG, Subramani R, Thomas A, Jaggarajamma K, Narayanan PR. Default during the intensive phase of the treatment under DOTS programme. Indian J Tuberc 2005;52:197-202. (Pubitemid 43018957)
6. Kolappan C, Subramani R, Karunakaran K, Narayanan PR. Mortality of tuberculosis patients in Chennai, India. Bull World Health Organ 2006;84:555-60. (Pubitemid 44186353)
7. Chang KC, Leung CC, Yew WW, Ho SC, Tam CM. A nested casecontrol study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med 2004;170:1124-30. (Pubitemid 39488627)
8. Qayyum S, Ahmed I, Ansari G. Comparing Daily Versus partially Intermittent Regimen of ATT in non-HIV patients with new Pulmonary Tuberculosis (TB) in DOTS program. Availble from: http://www.pjcm.net/pdf-v16-n1-p3.pdf [Last accessed on 2012 Jan 12].
9. Wells WA, Konduri N, Chen C, Ignatius HR, Gardiner E, Schwalbe NR. Implications of the current tuberculosis treatment landscape for future regimen change. Int J Tuberc Lung Dis 2011;15:746-53.
10. Iseman MD. Good news and not such good news. Int J Tuberc Lung Dis 1999;3:87.
11. World Health Organization. Anti-tuberculosis drug resistance in the world, Report No. 4. WHO.HTM/TB/2008.394 Geneva: World Health Organization Press; 2008.
12. World Health Organization. Treatment of Tuberculosis: Guidelines. 4th ed. Geneva: World Health Organization Press; 2010.
13. Available from: http://www.nature.com/news/totally-drugresistant-tb- emerges-in-india-1.9797. [Last accessed on 2012 Jan 12].
14. Tiwari P, Soneja M, Sharma SK. Tuberculosis management-Time for paradigm shift? Indian J Tuberc 2011;58:97-101.
15. Galbraith JK. The Affluent Society. Boston: Houghton Mifflin Company; 1958.
16. Illich I. Medical Nemesis: The expropriation of health. London: Marian Boyars; 1975.